September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Pharmacokinetics of Chemotherapy Delivery for Retinoblastoma
Author Affiliations & Notes
  • David H Abramson
    Memorial Sloan Kettering Cancer, New York, New York, United States
    Ophthalmology, Weill Cornell Medical School, New York, New York, United States
  • Footnotes
    Commercial Relationships   David Abramson, None
  • Footnotes
    Support  NONE
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      David H Abramson; Pharmacokinetics of Chemotherapy Delivery for Retinoblastoma. Invest. Ophthalmol. Vis. Sci. 2016;57(12):No Pagination Specified.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Presentation Description : Chemotherapy has been used for intraocular and extraocular retinoblastoma with success for more than 50 years worldwide. As a result lives, eyes and vision have been saved and patients with metastatic retinoblastoma have obtained long term cures. Clinical and laboratory evidence provide extensive information about drug pharmacokinetics and this presentation will summarize the known information about intravenous, intrarterial, periocular and intravitreal administration of Melphalan, Carboplatin and Topotecan (the thre drugs used most commonly)

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.